New look to an old symptom: Angina pectoris

Circulation

Volumn 96, Issue 10, 1997, Pages 3766-3773

  Crea, Filippo ^a   Gaspardone, Achille ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adenosine; Angina; Coronary disease; Receptors

Indexed keywords

SUBSTANCE P;

ANGINA PECTORIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART NERVE; HYPOTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

EID: 0030812557     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3766     Document Type: Review

References (119)

1. Colbeck EH. Angina pectoris: a criticism and a hypothesis. Lancet. 1903;1:793-795.
2. Lewis T. Pain in muscular ischemia: its relation to anginal pain. Arch Intern Med. 1932;49:713-727.
3. Davies G, Bencivelli W, Chierchia S, Fragasso G, Crea F, Crow J, Crean P, Pratt T, Morgan M, Maseri A. Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia. Circulation. 1988;78:310-319.
4. Sutton DC, Leuth HC. Experimental production of pain on excitation of the heart and great vessels. Arch Intern Med. 1930;45: 827-867.
5. Malliani A, Lombardi F, Pagani M. Sensory innervation of the heart. In: Cervero F, Morrison JFB, eds. Visceral Sensations: Progress in Brain Research, vol 67. Amsterdam, Netherlands: Elsevier; 1986:39-48.
6. Tomai F, Crea F, Gaspardone A, Versaci F, Esposito C, Chiariello L, Gioffrè PA. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol. 1993;22:1892-1896.
7. Sylven C, Beermann B, Jonzon B, Brandt R. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J. 1986;293:227-230.
8. Haneda T, Ichihra K, Abiko Y, Onodera S. Release of adenosine and lactate from human hearts during atrial pacing in patients with ischemic heart disease. Clin Cardiol. 1989;12:76-82.
9. Crea F, Pupita G, Galassi AR, El-Tamimi H, Kaski JC, Davies G, Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation. 1990;81:164-172.
10. Lagerqvist B, Sylven C, Beermann B, Helmius G, Waldenstrom A. Intracoronary adenosine causes angina pectoris like pain: an inquiry into the nature of visceral pain. Cardiovasc Res. 1990;24: 609-613.
11. Crea F, Gaspardone A, Kaski JC, Davies G, Maseri A. Relation between stimulation site of cardiac afferent nerves by adenosine and location of cardiac pain in patients with stable angina. J Am Coll Cardiol. 1992;20:1498-1504.
12. Sylven C, Jonzon B, Borg G, Fredholm BB, Kaijser L. Adenosine injection into the brachial artery produces ischemia-like pain or discomfort in the forearm. Cardiovasc Res. 1988;22:674-678.
13. Sylven C, Jonzon B, Edlund A. Angina pectoris like pain provoked by iv bolus of adenosine: relationship to coronary sinus blood flow, heart rate and blood pressure in healthy volunteers. Eur Heart J. 1989;10:48-54.
14. Jonzon B, Sylven C, Kaijser L. Theophylline decreases pain in the ischemic forearm test. Cardiovasc Res. 1989;23:807-809.
15. Crea F, Galassi AR, Kaski JC, Davies G, Maseri A. Effect of theophylline on exercise-induced myocardial ischemia. Lancet. 1989;1:683-686.
16. Sylven C, Jonzon B, Brandt R, Beermann B. Adenosine provoked angina pectoris-like pain: time characteristics, influence of autonomic blockade and naloxone. Eur Heart J. 1987;8:738-743.
17. Sylven C. Angina pectoris: clinical characteristics, neurophysiological and molecular mechanisms. Pain. 1989;36:145-167.
18. Sylven C, Beermann B, Kaijser L, Jonzon B. Nicotine enhances angina pectoris-like chest pain and atrioventricular blockade provoked by intravenous bolus of adenosine in healthy volunteers. J Cardiovasc Pharmacol. 1990;16:962-965.
19. Sylven C. Mechanisms of pain in angina pectoris: a critical review of the adenosine hypothesis. Cardiovasc Drugs Ther. 1993;7: 745-759.
20. Gaspardone A, Crea F, Tomai F, Iamele M, Crossman D, Pappagallo M, Versaci F, Chiariello L, Gioffrè PA. Substance P potentiates the algogenic effects of the intra-arterial infusion of adenosine. J Am Coll Cardiol. 1994;24:477-482.
21. van Calker D, Muller M, Hamprecht B. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979;33:999-1005.
22. Londos C, Cooper DMF, Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci USA. 1980;77:2551-2554.
23. Burnstock G. Vascular control by purines with emphasis on the coronary system. Eur Heart J. 1989;10:15-21.
24. Bohm M, Ungerer M, Erdmann E. Adenosine receptors in the human heart: pharmacological characterization in nondiseased and cardiomyopathic tissue. Drug Dev Res. 1993;28:268-276.
25. Lerman BB. Belardinelli L, Cardiac electrophysiology of adenosine. Circulation. 1991;83:1499-1509.
26. Belardinelli L. Adenosine system in the heart. Drug Dev Res. 1993;28:263-267.
27. Kusachi S, Thompson RD, Olsson RA. Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther. 1983;227: 316-321.
28. Leung E, Johnston CI, Woodcock EA. An investigation of the receptors involved in the coronary vasodilatory effect of adenosine analogues. Clin Exp Pharmacol Physiol. 1985;12:515-519.
29. Schrader J, Kroll K, Henrich M, Piper HM. Coronary and myocardial adenosine receptors. Biomed Biochem Acta. 1987;46: S421-S426.
30. Dodion L, Aylward M. Metabolic and pharmacokinetic studies on bamiphylline: a review. Rev Inst Hygiene Mines. 1978;33:204-210.
31. Dodion L, Dusart P, Temmerman P. Study on the metabolism of bamiphylline in man. Arzneimittelforsch Drug Res. 1969;19:785-789.
32. Foutillan JP, Lefebvre MA, Ingrand I, Patte F, Boita F, Ouchni MM. Pharmacokinetic study of bamiphylline (and metabolites) in healthy volunteers using chromatography and mass spectrometry. Therapie. 1983;38:647-658.
33. Bongrani S, Razzetti R, Papotti M. Pastore F, Bergamaschi M. Lack of cardiostimulant effects of bamiphylline in in vitro and in vivo models. Arzneimittelforsch Drug Res. 1990;40:169-174.
34. Moret PR, Fournet PC, Boufas D. Propriétés hemodynamiques d'un nouveau dérivé de la theophylline: la bamiphylline. Schweiz Med Wochenschr. 1970;100:462-467.
35. 1-receptors in rat brain. Pharmacol Res Commun. 1987;19:537-545.
36. Pappagallo M, Gaspardone A, Tomai F, Iamele M, Crea F, Gioffrè PA. Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. Pain. 1993;53:199-204.
37. 1 receptors. J Am Coll Cardiol. 1995;25: 251-257.
38. 1 adenosine receptor-mediated effects in humans. Circulation. 1996;93:1871-1876.
39. Gaspardone A, Crea F, Iamele M, Tomai F, Versaci F, Pellegrino A, Chiariello L, Gioffrè PA. Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action. Circulation. 1993;88:502-508.
40. Uchida Y, Kamisaka K, Ueda H. Responses of the cardiac sympathetic receptors to various substances. Jpn Heart J. 1969;10: 225-242.
41. MacDonald RL, Skerritt JH, Werz MA. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurons in cell culture. J Physiol. 1987;370:75-90.
42. Katholi RE, Hageman GR, Whinlow Woods WT. Hemodynamics and afferent renal nerve response to intrarenal adenosine in the dog. Hypertension. 1983;5(suppl 1):I-149-I-151.
43. McQueen DS, Ribeiro JA. Effects of adenosine on carotid chemoceptors activity in the cat. Br J Pharmacol. 1981;74:129-136.
44. Monteiro EC, Ribeiro JA. Ventilation effects of adenosine mediated by carotid baro-chemoceptors in the rat. Arch Pharmacol. 1987;35:143-148.
45. Biagioni I, Costa F. Adenosine activates afferent fibers in the forearm producing sympathetic activation in humans. J Pharmacol Exp Ther. 1993;267:1369-1375.
46. Montano N, Lombardi F, Ruscone TC, Conti M, Guazzi M, Malliani A. The excitatory effect of adenosine on the discharge activity of the afferent cardiac sympathetic fibers. Cardiologia. 1992;36:953-959.
47. Dibner-Dunlap ME, Kinugawa T, Thames MD. Activation of cardiac sympathetic afferents: effects of exogenous adenosine and adenosine analogues. Am J Physiol. 1993;265:H395-H400.
48. 1) receptors to cardiac afferent neurons in adult rats. Circulation. 1995;92(suppl I):I-134. Abstract.
49. Noordenbos W. Pain. Amsterdam, Netherlands: Elsevier; 1959: 254-265.
50. Perl ER. Is pain a specific sensation? J Psychiatric Res. 1971;8: 273-287.
51. Burgess PR, Perl ER. Cutaneous mechanoreceptors and nociceptors. In: Iggo A, ed. Handbook of Sensory Physiology: Somatosensory System (Vol. 2). New York, NY: Springer-Verlag; 1973: 29-78.
52. Malliani A, Recordati G, Schwartz PJ. Nervous activity of afferent cardiac sympathetic fibers with atrial and ventricular endings. J Physiol. 1973;229:457-469.
53. Lombardi F, Della Bella P, Casati R, Malliani A. Effects of intracoronary administration of bradykinin on the impulse activity of afferent sympathetic unmyelinated fibers with left ventricular endings in the cat. Circ Res. 1981;48:69-75.
54. Montano N, Lombardi F, Gnecchi-Ruscone T, Contini M, Guazzi M, Malliani A. Effetto eccitatorio dell'adenosina sull'attività di scarica delle fibre afferenti cardiache. Cardiologia. 1992;36: 953-959.
55. Montano N, Gnecchi-Ruscone T, Lombardi F, Malliani A, Excitatory effect of adenosine on cardiac sympathetic afferent fibers. In: Belardinelli L, Pelleg A, eds. Adenosine and Adenine Nucleotide: From Molecular Biology to Integrative Physiology. Boston, Mass: Kluwer Academic Publishers; 1995:307-314.
56. Malliani A. The elusive link between transient myocardial ischemia and pain. Circulation. 1986;73:201-204.
57. Malliani A. Cardiovascular sympathetic afferent fibres. Rev Physiol Biochem Pharmacol. 1982;94:11-74.
58. Malliani A, Pagani M, Lombardi F. Visceral versus somatic mechanisms. In: Wall PD, Melzack R, eds. Textbook of Pain. 2nd ed. Edinburgh, UK: Churchill Livingstone; 1989:128-140.
59. Gaspardone A, Crea F, Versaci F, Tomai F, Iamele M, De Fazio A, Perino M, De Fazio A, Chiariello L, Gioffrè PA. Algogenic effect of intracoronary infusion of adenosine at different coronary sites. Circulation. 1996;94(suppl I):I-571. Abstract.
60. Sylven C, Crea F. Mechanism of anginal pain: the key role of adenosine. In: Belardinelli L, Pelleg A, eds. Adenosine and Adenine Nucleotide: From Molecular Biology to Integrative Physiology. Boston, Mass: Kluwer Academic Publishers; 1995:315-325.
61. Maseri A, Crea F, Kaski JC, Davies G. Mechanisms and significance of cardiac ischemic pain. Prog Cardiovasc Dis. 1992;35:1-18.
62. Heberden W. Some account of a disorder of the breast. Med Trans. 1972;2:59-67.
63. Schang SJ, Pepine CJ. Transient asymptomatic ST segment depression during daily activity. Am J Cardiol. 1977;39:396-402.
64. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, Hilton-Chalfen S, Hestrin L, Bietendorf J, Berman DS. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 1988;318: 1005-1012.
65. Deanfield JE, Shea M, Ribiero P, de Landsheere CM, Wilson RA, Horlock P, Selwyn AP. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol. 1984;54:1195-1200.
66. Guazzi M, Fiorentini C, Polese A, Magrini F. Continuous electrocardiographic recording in Prinzmetal's variant angina pectoris: a report of four cases. Br Heart J. 1970;32:611-616.
67. Guazzi M, Magrini F, Fiorentini C, Polese A. Clinical, electrocardiographic and hemodynamic effects of long-term use of propranolol in Prinzmetal's variant angina pectoris. Br Heart J. 1971;33: 889-894.
68. Chierchia S, Marchesi C, Maseri A. Evidence of angina not caused by increased myocardial metabolic demand and pattern of electrocardiographic and hemodynamic alterations during 'primary' angina. In: Maseri A, Klassen GA, Lesch M, eds. Primary and Secondary Angina Pectoris. New York, NY: Grune & Stratton; 1978:145-153.
69. Chierchia S, Brunelli C, Simonetti I, Lazzari M, Maseri A. Sequence of events in angina at rest: primary reduction in coronary flow. Circulation. 1980;61:759-768.
70. Biagini A, Mazzei MG, Carpeggiani C, Testa R, Antonelli R, Maseri A. Vasospastic ischemic mechanism of frequent asymptomatic transient ST-T changes during continuous electrocardiographic monitoring in selected unstable angina patients. Am Heart J. 1982;103:13-20.
71. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214-1219.
72. Maseri A, Parodi O, Severi S, Pesola A. Transient transmural reduction of myocardial blood flow, demonstrated by thallium-201 scintigraphy, as a cause of variant angina. Circulation. 1976;54: 280-287.
73. Kaski JC, Crea F, Nihoyannopoulos P, Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol. 1986;58:1242-1247.
74. Kannel WB. Incidence, precursors and prognosis of unrecognized myocardial infarction. In: Kellermann JJ, Braunwald E, eds. Silent Myocardial Ischemia: A Critical Appraisal, vol 37. Basel, Switzerland: Karger; 1990:202-214.
75. Chierchia S, Lazzari M, Freedman B, Brunelli C, Maseri A. Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol. 1983;1:924-930.
76. Blair RW, Weber RN, Foreman RD. Characteristics of primate spinothalamic tract neurons receiving viscerosomatic convergent inputs in T3-T5 segments. J Neurophysiol. 1981;46:797-811.
77. Hillarp NA. Peripheral autonomie mechanisms. In: Field J, Braunwald E, eds. Handbook of Physiology, Section 1. Washington, DC: American Physiology Society; 1960:979-1006.
78. Brown AM. Excitation of afferent cardiac sympathetic nerve fibers during myocardial ischemia. J Physiol. 1967;190:35-53.
79. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience. 1992;48:501-524.
80. Meller ST, Lewis SJ, Ness TJ, Brody MJ, Gebhart GF. Vagal afferent-mediated inhibition of a nociceptive reflex by intravenous serotonin in the rat, I: characterization. Brain Res. 1990;524: 90-100.
81. Randall WC, Szentiuryi M, Pace JB, Wechsler JS, Kaye MP. Patterns of sympathetic nerve projections onto the canine heart. Circ Res. 1968;22:315-323.
82. Weaver LC, Danos LM, Oehl RS, Meckler RL. Contrasting reflex influences of cardiac afferent nerves during coronary occlusion. Am J Physiol. 1981;240:H620-H629.
83. Inoue H, Zipes DP. Increased afferent vagal responses produced by epicardial application of nicotine on the canine posterior left ventricle. Am Heart J. 1987;114:757-764.
84. Kositskii GI, Mikhailova SD, Semushkina TM. Unit activity of the ganglion nodosum in myocardial ischemia. Bull Exp Med Biol. 1985;98:1622-1624.
85. Eriksson B, Vuorisalo D, Sylven C. Diagnostic potential of chest pain characteristics in coronary care. J Intern Med. 1994;235: 473-478.
86. Pasceri V, Cianflone D, Finocchiaro ML, Crea F, Maseri A. Relation between myocardial infarction site and pain location in Q wave acute myocardial infarction. Am J Cardiol. 1995;75:224-230.
87. Lichstein E, Breitbart S, Shani J, Hollander G, Greengart A. Relationship between location of chest pain and site of coronary artery occlusion. Am Heart J. 1988;115:564-568.
88. Gallino A, Chierchia S, Smith G, Croom M, Morgan M, Marchesi C, Maseri A. Computer system for analysis of ST segment changes on 24 hour Holler monitor tapes: comparison with other available systems. J Am Coll Cardiol. 1984;4:245-252.
89. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499-506.
90. Rosen SD, Paulesu E, Frith CD, Frackowiac RS, Davies GJ, Jones T, Camici PG. Central nervous pathways mediating angina pectoris. Lancet. 1994;344:147-150.
91. Armour JA, Hopkins DA. Activity of in vivo canine ventricular neurons. Am J Physiol. 1990;258:H326-H336.
92. Huang MH, Smith FM, Armour JA. Amino acids modify the activity of canine intrinsic cardiac neurons involved in cardiac regulation. Am J Physiol. 1993;264:H1275-H1282.
93. Huang MH, Sylven C, Smith FM, Pelleg F. Modulation of in situ canine intrinsic cardiac neuronal activity by locally applied adenosine, ATP or analogs. Am J Physiol. 1993;265:H914-H922.
94. Huang MH, Sylven C, Horackova M, Armour JA. Ventricular sensory neurons in canine dorsal root ganglia: effects of adenosine and substance P. Am J Physiol. 1995;269:H318-H324.
95. Armour JA, Huang MH, Pelleg A, Sylven C. Responsiveness of in situ canine model ganglion afferent neurons to epicardial mechanical or chemical stimuli. Cardiovasc Res. 1994;28: 1218-1225.
96. Sylven C, Eriksson B, Jenson J, Geignt E, Hallin RG. Analgesic effects of adenosine during exercise-provoked myocardial ischemia. Neuroreport. 1996;7:1-5.
97. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
98. Droste C, Roskamm H. Experimental pain measurements in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol. 1983;1:940-945.
99. Glazier JJ, Chierchia S, Brown M, Maseri A. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol. 1986;58:667-672.
100. Falcone C, Sconocchia R, Guasti L, Codega S, Montemartini C, Specchia G. Dental pain threshold and angina pectoris in patients with coronary artery disease. J Am Coll Cardiol. 1988;12:348-352.
101. Akil H, Madden J, Patrick RL. Stress-induced increase in endogenous opiate peptides: concurrent analgesia and its partial reversal by naloxone. In: Kosterlitz HW, ed. Opiates and Endogenous Opioid Peptides. Amsterdam, Netherlands: Elsevier; 1976:63-70.
102. Basbaum A, Fields H. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7: 309-338.
103. Mayer DJ, Watkins LR. Multiple endogenous opiate and non-opiate analgesia systems. In: Kruger L, Liebeskind JC, eds. Advances in Pain Research and Therapy, vol 6. New York, NY: Raven Press; 1984:523-576.
104. Van Rijn, Rabkin SW. Effect of naloxolone on exercise-induced angina pectoris: a randomized double blind crossover trial. Life Sci. 1981;38:609-615.
105. Ellestad MH, Kuan P. Naloxone and asymptomatic ischemia: failure to induce angina during exercise testing. Am J Cardiol. 1984;54:982-984.
106. Droste C, Meyer-Blankenburg H, Greenlee MW. Effect of physical exercise on pain thresholds and plasma beta-endorphins in patients with silent and symptomatic myocardial ischemia. Eur Heart J. 1988;9(suppl N):25-33.
107. Falcone C, Specchia G, Rondanelli R, Guasti L, Corsico G, Codega S, Montemartini C. Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease. J Am Coll Cardiol. 1988;11:719-723.
108. Perna G, Stanislao M, Salvatori MP. Basal plasma beta-endorphin and beta-lipotropin in patients with symptomatic and asymptomatic myocardial ischemia. Cardiologia. 1988;33:765-769.
109. Opasich C, Cobelli F, Farilla C. Silent ischaemia in post-myocardial infarction patients submitted to physical training. Eur Heart J. 1988;9(suppl N):22-27.
110. Meisenberg G, Simmons WH. Peptides and the blood brain barrier. Life Sci. 1983;32:2611-2623.
111. Rosen SD, Paulesu E, Nihoyannopoulos P, Tousoulis D, Frackowiak RJJ, Frith CD, Jones T, Camici PG. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med. 1996;124:939-949.
112. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham Study. N Engl J Med. 1984;311:1144-1147.
113. Bradley RF, Partamian JO. Coronary heart disease in the diabetic patient. Med Clin North Am. 1963;78:1093-1104.
114. Bradley RF, Schoenfield SJ. Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics. 1962;17:322-326.
115. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS Jr. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med. 1988;108:170-175.
116. Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M. Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J. 1985;110: 529-534.
117. Fearman I, Faccio E, Melei J, Numez R, Jedzinsky M, Fox D, Rappaport M. Autonomic neuropathy and painless myocardial infarction in diabetic patients: histologic evidence of their relationships. Diabetes. 1977;26:1147-1158.
118. Niakan E, Harati Y, Rolak L, Comstock J, Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med. 1986;146:2222-2230.
119. Caracciolo EA, Chaitman BR, Forman SA, Stone PH, Bourassa MG, Sopko G, Nancy LG, Conti CR. Diabetics with coronary artery disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients: an ACIP database study. Circulation. 1996;93:2097-2105.